Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

Ricky Tirtakusuma, Katarzyna Szoltysek, Paul Milne, Vasily V. Grinev, Anetta Ptasinska, Paulynn S. Chin, Claus Meyer, Sirintra Nakjang, Jayne Y. Hehir-Kwa, Daniel Williamson, Pierre Cauchy, Peter Keane, Salam A. Assi, Minoo Ashtiani, Sophie G. Kellaway, Maria R. Imperato, Fotini Vogiatzi, Elizabeth K. Schweighart, Shan Lin, Mark Wunderlich, Janine Stutterheim, Alexander Komkov, Elena Zerkalenkova, Paul Evans, Hesta McNeill, Alex Elder, Natalia Martinez-Soria, Sarah E. Fordham, Yuzhe Shi, Lisa J. Russell, Deepali Pal, Alex Smith, Zoya Kingsbury, Jennifer Becq, Cornelia Eckert, Oskar A. Haas, Peter Carey, Simon Bailey, Roderick Skinner, Natalia Miakova, Matthew Collin, Venetia Bigley, Muzlifah Haniffa, Rolf Marschalek, Christine J. Harrison, Catherine A. Cargo, Denis Schewe, Yulia Olshanskaya, Michael J. Thirman, Peter N. Cockerill, James C. Mulloy, Helen J. Blair, Josef Vormoor, James M. Allan, Constanze Bonifer, Olaf Heidenreich, Simon Bomken

Blood (2022) 140 (17): 1875–1890.

https://doi.org/10.1182/blood.2021015036

Published: 2022

Includes: Supplemental data

Journal Articles

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Blood (2022) 140 (14): 1635–1649.

https://doi.org/10.1182/blood.2022015506

Published: 2022

Includes: Supplemental data

Journal Articles

In vivo T-depleted reduced-intensity transplantation for GATA2 -related immune dysfunction

Eleni Tholouli, Katherine Sturgess, Rachel E. Dickinson, Andrew Gennery, Andrew J. Cant, Graham Jackson, Jim Lordan, Sophie Hambleton, Mary A. Slatter, Venetia Bigley, Matthew Collin

Blood (2018) 131 (12): 1383–1387.

https://doi.org/10.1182/blood-2017-10-811489

Published: 2018

Includes: Supplemental data

Journal Articles

Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency

Blood (2018) 131 (8): 917–931.

https://doi.org/10.1182/blood-2017-09-807487

Published: 2018

Journal Articles

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

Paul Milne, Venetia Bigley, Chris M. Bacon, Antoine Néel, Naomi McGovern, Simon Bomken, Muzlifah Haniffa, Eli L. Diamond, Benjamin H. Durham, Johannes Visser, David Hunt, Harsha Gunawardena, Mac Macheta, Kenneth L. McClain, Carl Allen, Omar Abdel-Wahab, Matthew Collin

Blood (2017) 130 (2): 167–175.

https://doi.org/10.1182/blood-2016-12-757823

Published: 2017

Includes: Supplemental data

Journal Articles

Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells

Blood (2017) 129 (14): 1927–1939.

https://doi.org/10.1182/blood-2016-08-734236

Published: 2017

Includes: Supplemental data

Journal Articles

CD1c + blood dendritic cells have Langerhans cell potential

Paul Milne, Venetia Bigley, Merry Gunawan, Muzlifah Haniffa, Matthew Collin

Blood (2015) 125 (3): 470–473.

https://doi.org/10.1182/blood-2014-08-593582

Published: 2015

Includes: Supplemental data

Journal Articles

Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8 K108E mutation

Sandra Salem, David Langlais, François Lefebvre, Guillaume Bourque, Venetia Bigley, Muzz Haniffa, Jean-Laurent Casanova, David Burk, Albert Berghuis, Karina M. Butler, Timothy Ronan Leahy, Sophie Hambleton, Philippe Gros

Blood (2014) 124 (12): 1894–1904.

https://doi.org/10.1182/blood-2014-04-570879

Published: 2014

Includes: Supplemental data

Journal Articles

The evolution of cellular deficiency in GATA2 mutation

Blood (2014) 123 (6): 863–874.

https://doi.org/10.1182/blood-2013-07-517151

Published: 2014

Includes: Supplemental data

Journal Articles

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Kile Green, BSc(Hons), Rob Sellar, MD, Laura Jardine, MD, Janice Ward, Paul Ferguson, MD, Pip Nicolson, MD, Kim Pearce, PhD, Venetia Bigley, MD, PhD, Graham Jackson, MD, Sandeep Nagra, MD, Anne M Dickinson, PhD, Kirsty Thomson, MD, Stephen Mackinnon, MD, Charles Craddock, MD, Matthew P. Collin, MD, PhD, Karl S Peggs, MD

Blood (2013) 122 (21): 4540.

https://doi.org/10.1182/blood.V122.21.4540.4540

Published: 2013

Journal Articles

Hematopoietic Stem Cells and Circulating Myelomonocytic Precursors With BRAF-V600E Are Identified In High-Risk Patients and Define LCH As a Myeloid Neoplasia

Karen Phaik-Har Lim, MS, Tricia L Peters, MD, MS, Marie-Luise Berres, MD, Jeremy Price, Hitoshi Takizawa, PhD, Philip Lupo, PhD, M. John Hicks, MD, PhD, DDS, Albert Shih, Stephen James Simko, III, MD, Kenneth Matthew Heym, MD, Venetia Bigley, MD, PhD, Matthew P. Collin, MD, PhD, Markus G. Manz, MD, Kenneth McClain, MD, PhD, Miriam Merad, MD, PhD, Carl E. Allen, MD, PhD

Blood (2013) 122 (21): 103.

https://doi.org/10.1182/blood.V122.21.103.103

Published: 2013

Journal Articles

Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation

Blood (2011) 118 (21): 2045.

https://doi.org/10.1182/blood.V118.21.2045.2045

Published: 2011

Journal Articles

Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency

Blood (2011) 118 (10): 2656–2658.

https://doi.org/10.1182/blood-2011-06-360313

Published: 2011

Includes: Supplemental data

Journal Articles

The Equilibration of Peripheral Blood and Tissue CD3+ T Cell Engraftment Is Influenced by Graft Versus Host Disease Following Reduced Intensity Conditioning Stem Cell Transplantation

Victoria Harries, Rachel Dickinson, PhD, Venetia Bigley, MD, Matthew Collin, MD, PhD

Blood (2010) 116 (21): 2546.

https://doi.org/10.1182/blood.V116.21.2546.2546

Published: 2010

Journal Articles

Connecting the dots: monocyte/DC and NK subsets in human peripheral blood

Venetia Bigley, Laura E. Spence, Matthew Collin

Blood (2010) 116 (15): 2859–2860.

https://doi.org/10.1182/blood-2010-05-285676

Published: 2010

Journal Articles

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Andrew Charlton, MD, Laura Spence, MD, Venetia Bigley, MD, Natasha Groves, PhD, Geoff Hale, PhD, Sarah Pagan, BSc, Brie E Turner, PhD, Gail Jones, MD, PhD, Graham H Jackson, MD, PhD, Anne M Dickinson, PhD, Matthew Collin, MD, PhD

Blood (2009) 114 (22): 3333.

https://doi.org/10.1182/blood.V114.22.3333.3333

Published: 2009

Journal Articles

Drug-Induced, NKG2D-Dependent Sensitization of ALL Cell Lines to NK Recognition.

Laura Spence, MD, Sophie Hambleton, MD, PhD, Venetia Bigley, MD, Sarah Pagan, Matthew Collin, MD, PhD

Blood (2009) 114 (22): 2024.

https://doi.org/10.1182/blood.V114.22.2024.2024

Published: 2009

NARROW

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

In vivo T-depleted reduced-intensity transplantation for GATA2 -related immune dysfunction

Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells

CD1c + blood dendritic cells have Langerhans cell potential

Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8 K108E mutation

The evolution of cellular deficiency in GATA2 mutation

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Hematopoietic Stem Cells and Circulating Myelomonocytic Precursors With BRAF-V600E Are Identified In High-Risk Patients and Define LCH As a Myeloid Neoplasia

Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation

Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency

The Equilibration of Peripheral Blood and Tissue CD3+ T Cell Engraftment Is Influenced by Graft Versus Host Disease Following Reduced Intensity Conditioning Stem Cell Transplantation

Connecting the dots: monocyte/DC and NK subsets in human peripheral blood

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Drug-Induced, NKG2D-Dependent Sensitization of ALL Cell Lines to NK Recognition.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only